Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
Completed
Eli Lilly and Company
Phase 3
2002-05-01
The purpose of this study is to determine if duloxetine is effective when compared to placebo
in preventing recurrence of major depressive disorder in patients who have responded to
open-label duloxetine treatment.
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
Completed
Eli Lilly and Company
Phase 3
2002-03-01
The purposes of this study are to determine whether an investigational drug can help patients
suffering from major depression with pain symptoms, and gather data on the safety of the
investigational drug including any side effects that might be associated with it.
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
Completed
Eli Lilly and Company
Phase 3
2002-12-01
The purposes of this study are to determine:
The safety of duloxetine and any side effects that might be associated with it.
Whether duloxetine can help patients with major depression.
The safety associated with switching from a medication you may be taking for depression to
taking duloxetine.
It is possible that information collected during this study will be analyzed by the sponsor
in the future to evaluate duloxetine for other possible uses or for other medical or
scientific purposes other than those currently proposed.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
